Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence

被引：0
|
作者：
Chabre, Olivier [1 ]
Muller, Marie [2 ]
Cristante, Justine [1 ]
Cracowski, Jean-Luc [3 ]
Gay, Emmanuel [4 ]
机构：
[1] Univ Grenoble Alpes, CHU Grenoble Alpes, CEA,UGA, Unite Mixte Rech,Serv Endocrinol,INSERM,UMR 1036, F-38000 Grenoble, France
[2] CHU Grenoble Alpes, Serv Endocrinol, Grenoble, France
[3] Grenoble Alpes Univ, Pharmacovigilance Dept, INSERM, UMR 1300,Lab HP2, Grenoble, France
[4] Univ Grenoble Alpes, CHU Grenoble Alpes, Serv Neurochirurg, Grenoble, France
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2022年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [41] Treatment, and retreatment, of Cushing's disease
    Utiger, RD
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (03): : 215 - 217
  • [42] Pioglitazone treatment in Cushing's disease
    Barbaro, D
    Lapi, P
    Orsini, P
    Pasquini, C
    Ciaccio, S
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (04) : 388 - 389
  • [43] Medical treatment of Cushing's Disease
    Cuevas-Ramos, Daniel
    Fleseriu, Maria
    MINERVA ENDOCRINOLOGICA, 2016, 41 (03) : 324 - 340
  • [44] Pasireotide for the treatment of Cushing's disease
    Arnaldi, Giorgio
    Boscaro, Marco
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (07) : 889 - 898
  • [45] The medical treatment of Cushing's disease
    Lamberts, Steven W.
    Feelders, Richard A.
    Hofland, Leo J.
    ENDOCRINE JOURNAL, 2010, 57 : S306 - S306
  • [46] Cyproheptadine treatment in Cushing's disease
    Tanakol, R
    Alagol, F
    Azizlerli, H
    Sandalci, O
    Terzioglu, T
    Berker, F
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1996, 19 (04) : 242 - 247
  • [47] Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing's disease
    Fontaine-Sylvestre, Cedric
    Letourneau-Guillon, Laurent
    Moumdjian, Robert A.
    Berthelet, France
    Lacroix, Andre
    PITUITARY, 2021, 24 (02) : 207 - 215
  • [48] Pasireotide for the treatment of Cushing's disease
    Colao, Annamaria
    Simeoli, Chiara
    De Leo, Monica
    Cozzolino, Alessia
    Pivonello, Rosario
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (07): : 557 - 567
  • [49] Treatment Options in Cushing's Disease
    Rizk, Ahmed
    Honegger, Juergen
    Milian, Monika
    Psaras, Tsambika
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [50] Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease
    Cédric Fontaine-Sylvestre
    Laurent Létourneau-Guillon
    Robert A. Moumdjian
    France Berthelet
    André Lacroix
    Pituitary, 2021, 24 : 207 - 215
12345